SHANGHAI (Financial Times) -- The trial of Wu Xiaohui, ex-chairman of acquisitive conglomerate Anbang Insurance Group, began in Shanghai on Wednesday, in a proceeding that will reveal more detail about the government's accusations of economic crimes ... ( read original story ...)
Trial of Anbang’s former chairman starts in Shanghai
SHANGHAI/BEIJING (Reuters ... as Beijing cracks down on big-spending conglomerates and financial risk. Anbang had been one of the most aggressive investors behind a wave of overseas acquisitions by Chinese firms that have attracted the attention of ... ( read original story ...)
CHINA LAUNCHES OIL FUTURES TO STAKE CLAIM ON ITS OWN BENCHMARK / THE FINANCIAL TIMES
The Shanghai International Energy Exchange (INE), the unit of ... At least 10 foreign entities have registered to trade the contract including JPMorgan, Bands Financial and Straits Financial Services. Regulatory hurdles mean “there will be a gentle ... ( read original story ...)
China Vice Premier Liu tells regulators financial risk crackdown is their priority
“To win the battle against financial risks is a priority of the country’s current ... Additional reporting by John Ruwitch in Shanghai; Editing by Alison Williams and Sam Holmes Our Standards:The Thomson Reuters Trust Principles. ( read original story ...)
Anbang’s former chairman Wu Xiaohui contests all charges against him: Shanghai court
came after the government trained its sights on acquisitive non-state firms amid a sweeping programme to lower debt and financial risk in the economy. Anbang declined to comment on the start of the trial at the Shanghai No. 1 Intermediate People's Court. ( read original story ...)
Former Anbang Insurance Group chairman put on trial in Shanghai
According to a statement released by the Shanghai No.1 Intermediate People's Court on Wednesday ... The statement declares that Wu submitted false financial reports and other inaccurate material concerning his investment insurance products to the regulator ... ( read original story ...)
China fast tracks IPO by leading biotech firm WuXi AppTec, in race as Asia’s hub for fundraising
WuXi AppTec, the mainland’s leading biotechnology firm which privatised in New York two years ago, has been given the green light to relist on the A-share market via an initial public offering (IPO) in Shanghai, just seven weeks after filing its application. ( read original story ...)